Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Monoclonal antibodies

Various toxicities and off label use of rituximab: 16 case reports

    This is a preview of subscription content, log in to check access.

    Reference

    1. Zappulo E, et al. Incidence and predictive risk factors of infective events in patients with multiple sclerosis treated with agents targeting CD20 and CD52 surface antigens. Open Forum Infectious Diseases 6: 1-9, No. 11, 21 Oct 2019. Available from: URL: http://doi.org/10.1093/ofid/ofz445

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Monoclonal antibodies. Reactions Weekly 1791, 182 (2020). https://doi.org/10.1007/s40278-020-75027-8

    Download citation